Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Charles River Laboratories defended its $1.6 billion...
The 8th ChinaBio® Investor Forum, held in Shanghai,...
An investment firm, Jana Partners LLC, announced its...
Qiming Venture Partners announced a 250 million RMB...
Charles River Labs defended its $1.6 billion acquisition...
Sino Biopharmaceutical raised $79 million for a single,...
Charles River Labs’ spectacular announcement that...
Trauson (Jiangsu) Holdings, an orthopedic products...
Charles River Laboratories and WuXi PharmaTech said they...
WuXi PharmaTech (药明康德) reported upbeat Q2...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China